Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kan Katayama

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|December 17, 2024
New Insights into Kidney DiseasesKan Katayama, Kaoru Dohi
International Journal of Molecular Sciences|May 27, 2026
Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of HyperkalemiaToshinori Hirai, Kan Katayama
Biomedicines|July 29, 2023
Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse ModelsRyosuke Saiki, Kan Katayama, Kaoru Dohi
Biomedicines|January 8, 2025
Special Issue "Nephrotic Syndrome: Pathomechanism, Diagnostics, and Novel Treatment Options"Kan Katayama, Ryosuke Saiki, Kaoru Dohi
World Journal of Nephrology|November 7, 2014
Searching for a treatment for Alport syndrome using mouse modelsKan Katayama, Shinsuke Nomura, Karl Tryggvason, et al.
Reports (MDPI)|July 25, 2025
Pneumonia-Masked Pulmonary Embolism in Nephrotic Syndrome: Diagnostic Value of V/Q Scintigraphy: A Case ReportRyosuke Saiki, Kan Katayama, Tomohiro Murata, et al.
Clinical and Experimental Nephrology|June 10, 2026
Coexistence of ANCA-associated glomerulonephritis and membranous nephropathy: a scoping reviewRyosuke Saiki, Kan Katayama, Mutsuki Mori, et al.
Clinical Kidney Journal|February 2, 2023
Type VI collagen-related nephropathyMutsuki Mori, Kan Katayama, Kensuke Joh, et al.
British Journal of Pharmacology|February 26, 2019
Novel molecular mechanisms in the inhibition of adrenal aldosterone synthesis: Action of tolvaptan via vasopressin V<sub>2</sub> receptor-independent pathwayYusuf Ali, Kaoru Dohi, Ryuji Okamoto, et al.
Internal Medicine (Tokyo, Japan)|July 2, 2025
Coronavirus Disease 2019-associated Minimal Change Disease: Transient Improvement Does Not Preclude the Need for Standard Therapy in a Case Report and Review of the LiteratureRyosuke Saiki, Kan Katayama, Enyo Akiyama, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|December 17, 2024
New Insights into Kidney DiseasesKan Katayama, Kaoru Dohi
International Journal of Molecular Sciences|May 27, 2026
Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of HyperkalemiaToshinori Hirai, Kan Katayama
Biomedicines|July 29, 2023
Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse ModelsRyosuke Saiki, Kan Katayama, Kaoru Dohi
Biomedicines|January 8, 2025
Special Issue "Nephrotic Syndrome: Pathomechanism, Diagnostics, and Novel Treatment Options"Kan Katayama, Ryosuke Saiki, Kaoru Dohi
World Journal of Nephrology|November 7, 2014
Searching for a treatment for Alport syndrome using mouse modelsKan Katayama, Shinsuke Nomura, Karl Tryggvason, et al.
Reports (MDPI)|July 25, 2025
Pneumonia-Masked Pulmonary Embolism in Nephrotic Syndrome: Diagnostic Value of V/Q Scintigraphy: A Case ReportRyosuke Saiki, Kan Katayama, Tomohiro Murata, et al.
Clinical and Experimental Nephrology|June 10, 2026
Coexistence of ANCA-associated glomerulonephritis and membranous nephropathy: a scoping reviewRyosuke Saiki, Kan Katayama, Mutsuki Mori, et al.
Clinical Kidney Journal|February 2, 2023
Type VI collagen-related nephropathyMutsuki Mori, Kan Katayama, Kensuke Joh, et al.
British Journal of Pharmacology|February 26, 2019
Novel molecular mechanisms in the inhibition of adrenal aldosterone synthesis: Action of tolvaptan via vasopressin V<sub>2</sub> receptor-independent pathwayYusuf Ali, Kaoru Dohi, Ryuji Okamoto, et al.
Internal Medicine (Tokyo, Japan)|July 2, 2025
Coronavirus Disease 2019-associated Minimal Change Disease: Transient Improvement Does Not Preclude the Need for Standard Therapy in a Case Report and Review of the LiteratureRyosuke Saiki, Kan Katayama, Enyo Akiyama, et al.
Pageof 8